William Atkins Tuesday, 15 May 2012 22:22

Science - Health

Page 1 of 2

According to a May 2012 study published in the journalNeurology, nearly1 out of 3 adults in the United States sleepwalk or, as the authors say, have nocturnal wanderings.

The French and American authors of the study include M.M. Ohayon, M.W. Mahowald, Y. Dauvilliers, A.D. Krystal, and D. Lger.

These researchers wanted to test how frequently people walk in their sleep, what they call nocturnal wandering with abnormal state of consciousness.

They sampled the general population of the United States, a representative sample of 19,136 noninstitutionalized adults from the U.S. population who were 18 years or older.

The researchers administered the Sleep-EVAL-expert system to these participants, asking they such questions as their life and sleeping habits, general health, and mental disorders.

The results of the study found that nocturnal wandering (NW) occurred in 29.2% of the participants.

The study also found the following:

The rest is here:
Nearly 30% of people sleepwalk! Are you one?

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0862104/India-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

India Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories.- Global corporate-level profiles of key companies operating within the India Neurology Devices market. - Key players covered include Terumo Corporation, Medtronic, Inc., DePuy, Inc., CareFusion Corporation, Stryker Corporation, Covidien plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the India Neurology Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.1 Table of Contents1 Table of Contents 21.1 List of Tables 71.2 List of Figures 92 Introduction 112.1 What Is This Report About? 113 Neurology Devices In India 123.1 Neurology Devices, Market Segmentation 123.2 Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 133.3 Neurology Devices Market, India, Revenue Mix ($m), 2011 153.4 Neurology Devices Market, India, Category Contribution (%), 2011 163.5 Neurology Devices, India, Company Share (2010-2011) 234 CSF Management In India 254.1 CSF Management, Market Segmentation 254.2 CSF Management Market, India, Revenue Mix ($m), 2011 264.3 CSF Management Market, India, Segment Contribution (%), 2011 274.4 CSF Management Overall Revenue, (2004-2018) 284.5 CSF Management Overall Volume (2004-2018) 324.6 CSF Management Average Price (2004-2018) 344.7 CSF Management Distribution Share (2010-2011) 354.8 CSF Management, India, Company Share (2010-2011) 365 Interventional Neurology In India 385.1 Interventional Neurology, Market.Segmentation 385.2 Interventional Neurology Market, India, Revenue Mix ($m), 2011 395.3 Interventional Neurology Market, India, Segment Contribution (%), 2011 405.4 Interventional Neurology Overall Revenue, (2004-2018) 415.4.1 Embolic Systems, Revenue (2004-2018) 455.4.2 Navigational Systems, Revenue (2004-2018) 495.5 Interventional Neurology Overall Volume (2004-2018) 535.5.1 Embolic Systems, Volume (2004-2018) 575.5.2 Navigational Systems, Volume (2004-2018) 595.6 Interventional Neurology Average Price (2004-2018) 615.7 Interventional Neurology Distribution Share (2010-2011) 625.8 Interventional Neurology, India, Company Share (2010-2011) 636 Neurological Diagnostic Equipment In India 656.1 Neurological Diagnostic Equipment, Market.Segmentation 656.2 Neurological Diagnostic Equipment Market, India, Revenue Mix ($m), 2011 666.3 Neurological Diagnostic Equipment Market, India, Segment Contribution (%), 2011 676.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 686.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 726.6 Neurological Diagnostic Equipment Average Price (2004-2018) 766.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 776.8 Neurological Diagnostic Equipment, India, Company Share (2010-2011) 787 Neurostimulation Devices In India 807.1 Neurostimulation Devices, Market Segmentation 807.2 Neurostimulation Devices Market, India, Revenue Mix ($m), 2011 817.3 Neurostimulation Devices Market, India, Segment Contribution (%), 2011 827.4 Neurostimulation Devices Overall Revenue, (2004-2018) 837.5 Neurostimulation Devices Overall Volume (2004-2018) 877.6 Neurostimulation Devices Average Price (2004-2018) 917.7 Neurostimulation Devices Distribution Share (2010-2011) 927.8 Neurostimulation Devices, India, Company Share (2010-2011) 938 Neurosurgical Products In India 958.1 Neurosurgical Products, Market Segmentation 958.2 Neurosurgical Products Market, India, Revenue Mix ($m), 2011 968.3 Neurosurgical Products Market, India, Segment Contribution (%), 2011 978.4 Neurosurgical Products Overall Revenue, (2004-2018) 988.5 Neurosurgical Products Overall Volume (2004-2018) 1028.6 Neurosurgical Products Average Price (2004-2018) 1048.7 Neurosurgical Products Distribution Share (2010-2011) 1058.8 Neurosurgical Products, India, Company Share (2010-2011) 1069 Radiosurgery In India 1089.1 Radiosurgery, Market Segmentation 1089.2 Radiosurgery Overall Revenue, (2004-2011) 1099.3 Radiosurgery Overall Volume (2004-2011) 1109.4 Radiosurgery Average Price (2004-2011) 1119.5 Radiosurgery Distribution Share (2010-2011) 1119.6 Radiosurgery, India, Company Share (2010-2011) 11110 Overview of Key Companies in India Neurology Devices Market 11210.1 Terumo Corporation 11210.1.1 Company Overview 11210.1.2 Share in the India Neurology Devices Market 11210.2 Medtronic, Inc. 11310.2.1 Company Overview 11310.2.2 Share in the India Neurology Devices Market 11310.3 DePuy, Inc. 11410.3.1 Company Overview 11410.3.2 Share in the India Neurology Devices Market 11410.4 CareFusion Corporation 11510.4.1 Company Overview 11510.4.2 Share in the India Neurology Devices Market 11510.5 Stryker Corporation 11610.5.1 Company Overview 11610.5.2 Share in the India Neurology Devices Market 11610.6 Covidien plc 11710.6.1 Company Overview 11710.6.2 Share in the India Neurology Devices Market 11710.7 Elekta AB 11810.7.1 Company Overview 11810.8 B. Braun Melsungen AG 11810.8.1 Company Overview 11810.9 Sophysa S.A. 11910.9.1 Company Overview 11910.10 Integra LifeSciences Holdings Corporation 11910.10.1 Company Overview 11910.11 Natus Medical Incorporated 12010.11.1 Company Overview 12010.12 St. Jude Medical, Inc. 12010.12.1 Company Overview 12010.13 Nihon Kohden Corporation 12110.13.1 Company Overview 12110.14 Christoph Miethke GmbH & Co. KG 12110.14.1 Company Overview 12110.15 KARL STORZ GmbH & Co. KG 12110.15.1 Company Overview 12110.16 Cadwell Laboratories, Inc. 12210.16.1 Company Overview 12210.17 Boston Scientific Corporation 12210.17.1 Company Overview 12210.18 Cyberonics, Inc. 12210.18.1 Company Overview 12210.19 G. Surgiwear Limited 12310.19.1 Company Overview 12311 Neurology Devices Market Pipeline Products 12412 Appendix 12912.1 Definitions of Markets Covered in the Report 13012.1.1 Neurology Devices 13012.2 Research Methodology 13412.3 Secondary Research 13412.4 Primary Research 13412.5 Models 13512.6 Forecasts 13512.7 Expert Panels 13612.8 GlobalData Consulting 13612.9 Currency Conversion 13612.10 Contact Us 13612.11 Disclaimer 136

List of Tables

Table 1: Neurology Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 14Table 2: Neurology Devices Market, India, Category Contribution (%), 2011 16Table 3: Neurology Devices, India, Cross-Category Analysis, 2004-2018 18Table 4: Neurology Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20Table 5: Neurology Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22Table 6: Neurology Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 24Table 7: CSF Management Market, India, Segment Contribution (%), 2011 27Table 8: CSF Management, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 29Table 9: CSF Management, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 31Table 10: CSF Management, India, Volume (Units) by Segment, Historic, 2004-2011 32Table 11: CSF Management, India, Volume (Units) by Segment, Forecast, 2011-2018 33Table 12: CSF Management, India, Average Price ($), Historic, 2004-2011 34Table 13: CSF Management, India, Average Price ($), Forecast, 2011-2018 34Table 14: CSF Management, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35Table 15: CSF Management, India, Company Share by Revenue ($m), USD Constant, 2010-2011 37Table 16: Interventional Neurology Market, India, Segment Contribution (%), 2011 40Table 17: Interventional Neurology, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 42Table 18: Interventional Neurology, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 44Table 19: Embolic Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 46Table 20: Embolic Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 48Table 21: Navigational Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50Table 22: Navigational Systems, India, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Table 23: Interventional Neurology, India, Volume (Units) by Segment, Historic, 2004-2011 54Table 24: Interventional Neurology, India, Volume (Units) by Segment, Forecast, 2011-2018 56Table 25: Embolic Systems, India, Volume (Units) by Sub-Segment, Historic, 2004-2011 57Table 26: Embolic Systems, India, Volume (Units) by Sub-Segment, Forecast, 2011-2018 58Table 27: Navigational Systems, India, Volume (Units) by Sub-Segment, Historic, 2004-2011 59Table 28: Navigational Systems, India, Volume (Units) by Sub-Segment, Forecast, 2011-2018 60Table 29: Interventional Neurology, India, Average Price ($), Historic, 2004-2011 61Table 30: Interventional Neurology, India, Average Price ($), Forecast, 2011-2018 61Table 31: Interventional Neurology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 62Table 32: Interventional Neurology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 64Table 33: Neurological Diagnostic Equipment Market, India, Segment Contribution (%), 2011 67Table 34: Neurological Diagnostic Equipment, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 69Table 35: Neurological Diagnostic Equipment, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 71Table 36: Neurological Diagnostic Equipment, India, Volume (Units) by Segment, Historic, 2004-2011 73Table 37: Neurological Diagnostic Equipment, India, Volume (Units) by Segment, Forecast, 2011-2018 75Table 38: Neurological Diagnostic Equipment, India, Average Price ($), Historic, 2004-2011 76Table 39: Neurological Diagnostic Equipment, India, Average Price ($), Forecast, 2011-2018 76Table 40: Neurological Diagnostic Equipment, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 77Table 41: Neurological Diagnostic Equipment, India, Company Share by Revenue ($m), USD Constant, 2010-2011 79Table 42: Neurostimulation Devices Market, India, Segment Contribution (%), 2011 82Table 43: Neurostimulation Devices, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 84Table 44: Neurostimulation Devices, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 86Table 45: Neurostimulation Devices, India, Volume (Units) by Segment, Historic, 2004-2011 88Table 46: Neurostimulation Devices, India, Volume (Units) by Segment, Forecast, 2011-2018 90Table 47: Neurostimulation Devices, India, Average Price ($), Historic, 2004-2011 91Table 48: Neurostimulation Devices, India, Average Price ($), Forecast, 2011-2018 91Table 49: Neurostimulation Devices, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 92Table 50: Neurostimulation Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 94Table 51: Neurosurgical Products Market, India, Segment Contribution (%), 2011 97Table 52: Neurosurgical Products, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 99Table 53: Neurosurgical Products, India, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 101Table 54: Neurosurgical Products, India, Volume (Units) by Segment, Historic, 2004-2011 102Table 55: Neurosurgical Products, India, Volume (Units) by Segment, Forecast, 2011-2018 103Table 56: Neurosurgical Products, India, Average Price ($), Historic, 2004-2011 104Table 57: Neurosurgical Products, India, Average Price ($), Forecast, 2011-2018 104Table 58: Neurosurgical Products, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 105Table 59: Neurosurgical Products, India, Company Share by Revenue ($m), USD Constant, 2010-2011 107Table 60: Radiosurgery, India, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 109Table 61: Radiosurgery, India, Volume (Units) by Segment, Historic, 2004-2011 110Table 62: Radiosurgery, India, Average Price ($), Historic, 2004-2011 111Table 63: Radiosurgery, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 111Table 64: Radiosurgery, India, Company Share by Revenue ($m), USD Constant, 2010-2011 111Table 65: Neurology Devices Market Pipeline Products 124

Excerpt from:
India Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Othershttp://www.reportlinker.com/p0862105/China-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData's new report, "China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the China Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the six market categories. - Global corporate-level profiles of key companies operating within the China Neurology Devices market. - Key players covered include Medtronic, Inc., Accuray Incorporated, DePuy, Inc., B. Braun Melsungen AG, CareFusion Corporation, St. Jude Medical, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the China Neurology Devices competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.

1 Table of Contents

The rest is here:
China Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

A Mayo Clinic dermatology art contest shows beauty really is skin deep. From Mayo Clinic News blog:

A hair follicle or skin specimen that doesn’t look like much of anything to the naked eye can become a complex, colorful work of art under a microscope. The winner of the Mayo dermatologists’ first art contest in 2011 was “Hair Follicle Triplet”. Alexander Meves, M.D., used fluorescent dyes to highlight proteins. The inaugural winners of the art contest appeared in the May issue of the Journal of Cutaneous Pathology.

“Every single day, dermatopathologists get to see beautiful images under the microscope, and most people never have the opportunity to see that. So I thought it would be a nice way to show not only the science of dermatopathology, but also the art,” says the contest’s creator, Dr. Lehman, a Mayo Clinic dermatopathologist.

Dr. Lehman hopes medical societies will run with the idea and hold similar competitions to highlight aesthetics in their specialties. People in other lines of work can also celebrate the beauty of what they do each day, she says.

Editor's note: Allergists should do something similar. We already highlight beautiful pollen allergens on the monthly covers of the ACAAI journal.

“Art can be seen in every aspect of life,” Dr. Lehman says. “You just have to have an open mind and be looking for it.”

References

Dermatology Art Shows Beauty Really Is Skin Deep. Mayo Clinic News.

Source:
http://feeds.feedburner.com/CasesBlog

Here are my suggestions for some of the top articles in medicine in May 2012 so far:

Is Geriatric Medicine Terminally Ill? asks Annals of Internal Medicine http://goo.gl/J4jMU

Low vitamin D (below 50 nmol/L (20 ng/mL) increases risk for clinical disease among older adults http://goo.gl/tBXS4

Senior physicians keep working, putting off the R-word - 20% of U.S. physicians are older than 65 http://goo.gl/Dxgip

Many young doctors worried about future of medicine - amednews http://goo.gl/r61lW

"One of the greatest risks of social media is ignoring social media" says chief integrity officer of Cleveland Clinic. Patients want to use social media tools to manage health care http://goo.gl/9SAry

Doctors can risk lawsuits when writing about patients - amednews points to books about patients as examples http://goo.gl/QhqFS

Coffee is the most complex food known to man. It has 1200 flavor components. The nearest comparison is red wine with 450 chemical compounds in the flavor make-up. In most commercial blends there are 10 to 12 different coffees, from different farms. http://goo.gl/m2LwD

Guidelines for social media use by Federation of State Medical Boards (FSMB) describe in detail what NOT to do: http://goo.gl/Raq2e

Prevention of acute knee injuries in adolescent female football (soccer) players: warm-up could help http://goo.gl/dBgSS

Is It Possible To Walk And Work At The Same Time? Kaiser Permanente tries walking meetings http://goo.gl/cRu8l

Corneal transplantation - 2012 state of the art review in The Lancet http://goo.gl/JBAag

Towards an optimum strategy in rheumatoid arthritis: For RA patients who fail initial methotrexate treatment, add-on disease-modifying antirheumatic drugs are appropriate http://goo.gl/ONq6u

Time Spent Behind the Wheel May Increase Heart Health Risks, linked to less time spent exercising http://goo.gl/NUYX7

Recipe For Safer Drinking Water (from bacteria)? Add Sun, Salt And Lime http://goo.gl/kU2ZK

The articles were selected from my Twitter and Google Reader streams.

Source:
http://feeds.feedburner.com/CasesBlog

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

http://www.reportlinker.com/p0862101/United-States-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData's new report, "United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the United States Neurology Devicesmarket.

The rest is here:
United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment ...

Diets that were tried in attempt to reduce symptoms associated with attention-deficit/hyperactivity disorder (ADHD) include:

- sugar-restricted
- additive/preservative-free
- oligoantigenic/elimination
- fatty acid supplements

Omega?3 supplement is the latest dietary treatment with positive reports of efficacy. Interest in the additive-free diet of the 1970s is occasionally revived.

Provocative reports have drawn attention to the ADHD-associated “Western-style” diet, high in fat and refined sugars, and the ADHD-free “healthy” diet, containing fiber, folate, and omega-3 fatty acids.

Indications for dietary therapy include:

- medication failure
- parental or patient preference
- iron deficiency
- change from an ADHD-linked Western diet to an ADHD-free healthy diet, when appropriate

In practice, additive-free and oligoantigenic/elimination diets are time-consuming and disruptive to the household; they are indicated only in selected patients.

Iron and zinc are supplemented in patients with known deficiencies; they may also enhance the effectiveness of stimulant therapy.

In patients failing to respond or with parents opposed to medication, omega-3 supplements may warrant a trial.

References:

The Diet Factor in Attention-Deficit/Hyperactivity Disorder. J. Gordon Millichap, MD and Michelle M. Yee, CPNP. PEDIATRICS Vol. 129 No. 2 February 1, 2012, pp. 330 -337, (doi: 10.1542/peds.2011-2199)

Image source: Olive oil, Wikipedia

Source:
http://feeds.feedburner.com/CasesBlog

Writing has long been used as a coping strategy and has been applied to improve psychological well-being. One study found that suicidal poets used more first-person singular pronouns (I, me, my) than the control group of poets.

This study from Taiwan, published in the Journal of Happiness Studies, investigated the psychological displacement paradigm in diary-writing (PDPD) and its supposed psychological benefits.

Study participants were randomly assigned to write about their recent negative life experiences two times a week for 2 weeks in PDPD group (diary-writing), or comparison group (no diary-writing).

The diary-writing group (PDPD) showed a decrease in negative emotion and an increase in positive emotion immediately after each writing session (short term effect).

They also had an increase in psychological well-being for at least 2 weeks (long term effect).

References:

The Psychological Displacement Paradigm in Diary-Writing (PDPD) and its Psychological Benefits. Jen-Ho Chang, Chin-Lan Huang and Yi-Cheng Lin. JOURNAL OF HAPPINESS STUDIES 2012, DOI: 10.1007/s10902-012-9321-y

Comments from Google Plus and Twitter:

Lin W: I guess blog writing might have the same effect??

Ves Dimov, M.D.: It depends on the type of blogging you do, but yes, blogging can be a positive experience too.?

Dr. Amal Hasan @DrFloona: Diary-Writing Has Psychological Benefits bit.ly/wwMDmr” Until someone else reads it

Dean Giustini @giustini: Diary-Writing Has Psychological Benefits bit.ly/wwMDmr [Isn't this why we blog Ves?]

@DrVes: Well, I'm not sure. I don't blog about "negative experiences". Blog = archive for me?

Source:
http://feeds.feedburner.com/CasesBlog

Public release date: 10-May-2012 [ | E-mail | Share ]

Contact: Jim Ritter jritter@lumc.edu 708-216-2445 Loyola University Health System

MAYWOOD, Ill. Loyola University Chicago Stritch School of Medicine student Jason Cuomo has received a 2012 American Academy of Neurology Medical Student Prize for Excellence in Neurology.

The award recognizes excellence in clinical neurology among medical students. The Stritch faculty selected Cuomo to receive the prize, which is awarded annually on behalf of the American Academy of Neurology. The award is given to a student who exemplifies outstanding scientific achievement and clinical acumen in neurology or neuroscience, and outstanding integrity, compassion and leadership.

"Jason is mature, inquisitive, eager to learn, motivated and highly responsible," said Dr. Jose Biller, chairman of the Department of Neurology. "He is a very accomplished and talented medical student."

Cuomo is completing his second year of medical school. He is active in Stritch's Honors in Research Program and is vice president of the Student Interest Group in Neurology. He is a co-author of nine academic articles, book chapters, abstracts and presentations.

Cuomo grew up in Guilford, Ct. He graduated from Boston College with double majors in psychology and philosophy, and has a master's degree in philosophy from Boston College.

###

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Link:
Loyola Med student wins prize for excellence in neurology

Newswise MAYWOOD, Ill. Loyola University Chicago Stritch School of Medicine student Jason Cuomo has received a 2012 American Academy of Neurology Medical Student Prize for Excellence in Neurology.

The award recognizes excellence in clinical neurology among medical students. The Stritch faculty selected Cuomo to receive the prize, which is awarded annually on behalf of the American Academy of Neurology. The award is given to a student who exemplifies outstanding scientific achievement and clinical acumen in neurology or neuroscience, and outstanding integrity, compassion and leadership.

Jason is mature, inquisitive, eager to learn, motivated and highly responsible, said Dr. Jos Biller, chairman of the Department of Neurology. He is a very accomplished and talented medical student."

Cuomo is completing his second year of medical school. He is active in Stritchs Honors in Research Program and is vice president of the Student Interest Group in Neurology. He is a co-author of nine academic articles, book chapters, abstracts and presentations.

Cuomo grew up in Guilford, Conn. He graduated from Boston College with a double major in psychology and philosophy, and has a masters degree in philosophy from Boston College.

The rest is here:
Loyola Med Student Wins Award for Excellence in Neurology

by MBJ Staff

Published: May 7,2012

Tags: clinic, diagnosis, doctors, health, health care, imaging, medical, medicine, physicians, scans, technology

HATTIESBURG Hattiesburg Clinic Neurology is the first in Mississippi to perform the recently FDA-approved DaTscan test, which helps physicians differentiate between essential tremor and parkinsonian syndromes, according to the clinic.

After the FDA approved DaTscan in May 2011, Hattiesburg Clinic Neurology performed the diagnostic imaging modality just two months later. On July 14, Wendell R. Helveston, M.D., and Ronald L. Schwartz, M.D., CPI, ordered the first DaTscans in Mississippi. Since this initial step, the clinic has successfully performed over 100 DaTscan tests.

The test is a significant step forward in physicians abilities to effectively diagnose and provide treatment to their patient with these symptoms, Helveston said. Currently, we diagnose these disorders based on clinical examinations, MRI and neuropsychological evaluations, but lacked a method that was specific and sensitive in the diagnosis of Parkinsons disease. This differentiation is paramount because the various disorders are treated differently.

To sign up for Mississippi Business Daily Updates, click here.

Originally posted here:
Hattiesburg Clinic pioneers new diagnostic scanning procedure

Here are my suggestions for some of the top articles related to healthcare social media in the past 2 weeks:

Doctors and social media: “How to Stop Worrying and Learn to Love the Internet” http://goo.gl/pIrgh

Consumer Expectations for Healthcare Social Media http://goo.gl/REXqV

Why all hospitals need Twitter accounts: Google ranking of a URL linked to number of Tweets about that URL http://goo.gl/AYf9t

Interviewee eliminated as a candidate because his Klout score was too low (34), “They hired a guy whose score was 67”. Even if you have no idea what your Klout score is, there’s a chance that it’s already affecting your life. People with formidable Klout will board planes earlier, get free access to VIP airport lounges, stay in better hotel rooms, and receive deep discounts from retail stores. A two-week vacation from social media might causes your Klout score to nose-dive. http://goo.gl/ABu2S

13 Things You Never Knew You Could Do On LinkedIn http://goo.gl/mh4da

100 Ways To Use Twitter In Education, By Degree Of Difficulty http://goo.gl/lAs5v

Pack the Right Gadgets for the Road - NYTimes http://goo.gl/SmQgA

A Review of Living Language and Rocket Languages - App Smart - NYTimes http://goo.gl/kpvJT

10 HTML Tags All New Bloggers Should Learn http://goo.gl/24FpW

Is this the future of Khan Academy? http://goo.gl/xtErX - Bozeman Biology on YouTube http://goo.gl/GUry5

Many consumers worldwide worry that technology is overtaking their lives http://goo.gl/cJj5e

The articles were selected from my Twitter and Google Reader streams.

Source:
http://feeds.feedburner.com/CasesBlog

Consumption of omega-3 rich foods could reduce the risk of Alzheimers by lowering levels of plasma beta-amyloid, according to new research.

Omega-3 intake could help to slow declines in cognitive functioning, suggest the researchers

The new study published in Neurology suggests that consumption of foods that contain high levels of omega-3 fatty acids may be associated with lower blood levels of the protein, which has been implicated in the onset of Alzheimer's disease and memory problems.

Led by Dr Nikolaos Scarmeas, of Columbia University Medical Center in New York, USA, the research team noted that previous research has shown increasing evidence that diet could play an important role in preventing or delaying the onset of Alzheimer disease.

Scarmeas revealed that consumption of one additional gram of omega-3 per day above the average omega-3 consumed by people in the study was associated with 20% to 30% lower blood beta-amyloid levels.

We found that higher dietary omega-3 polyunsaturated fatty acid intake was associated with lower plasma beta-amyloid42 level, suggesting that the potential beneficial effects of omega-3 PUFA intake on Alzheimers disease and cognitive function in the literature might be at least partly explained by an amyloid-beta-related mechanism.

Commenting on the study, Harry Rice, PhD, VP of regulatory andscientific affairs for the Global Organization for EPA and DHA Omega-3 (GOED) told NutraIngredients that whilst the research has limitations, the results are exciting given that they provide support for what many scientists have been speculating for a number of years.

Rice said that one the next steps would be to determine to what extent, if any, plasma beta-amyloid proteins reflect amyloid levels in the brain.

Scarmeas noted that while it is not easy to measure levels of beta-amyloid deposits in the brain, it is relatively easy to measure the levels of beta-amyloid in the blood, which, to a certain degree, relates to the level in the brain."

Visit link:
Omega-3 may reduce risk of Alzheimer’s: Study

Tips from ProBlogger on how to have a successful blog:

- Regular useful content: Daily “how to” posts that solved problems and showed people how to achieve their goals, 90%

- Shareable content: inspirational posts, breaking news, humor, controversy, grand list posts, 5%

- Community: reader discussions, debates, polls, forum, 5%

- Email newsletter: collect people’s email addresses and send them weekly updates/newsletters

Here is a great quote from another blog: "Blogging is teaching, whether it’s yourself or others, and that’s the best feeling in the world" http://goo.gl/hCpF8

References:

2 Different Tales of Blog Growth. ProBlogger.

Source:
http://feeds.feedburner.com/CasesBlog

Here are my suggestions for some of the top articles in medicine in April-May 2012:

Always advocate for the patient. When in a bind, ask yourself, “Self, what's best for my patient?” You can only see ONE patient at a time. The patient in front of you is the only patient you have. http://bit.ly/HGJcU8

Adolescence is changing: age of onset of puberty is decreasing, age at which mature social roles are achieved is rising http://goo.gl/dshDG

Pilot sends plane into dive after mistaking Venus for oncoming plane http://bit.ly/INqXjw - "It's happened to most of us", starts CNN... North American-based pilots flying eastbound at night towards Europe are at increased risk of fatigue-related performance issues http://bit.ly/INqXjw

Are we ready to recommend aspirin for cancer prevention? Lancet http://goo.gl/WyRXY and http://goo.gl/oytIK

First described in 1967, Kawasaki disease is now a leading cause of acquired heart disease in developed countries http://goo.gl/ShL00 -- Addition of prednisolone to standard treatment with IVIG improves coronary artery outcomes in severe Kawasaki disease http://j.mp/JdUbTl

Bullying victimisation is associated with a myriad of emotional and behavioural problems throughout adolescence http://goo.gl/VzBrf

Thoughts for new medical students http://goo.gl/cr5k3 - Advice from the BMJ editor in 2003, still mostly relevant.

Consumer Expectations for Healthcare Social Media http://goo.gl/REXqV

Women are much more responsive than men to the weather, and life satisfaction decreases with rain (study) http://goo.gl/gp5KE

Use of Social Media by Western European Hospitals: Longitudinal Study shows that SoMe awareness is growing http://goo.gl/l41tz

Geriatrics update 2012: What parts of our practice to change, what to ‘think about’ - CCJM http://goo.gl/rvH9O

Family history: Still relevant in the genomics era - CCJM http://goo.gl/ty5vG

The articles were selected from my Twitter and Google Reader streams.

Source:
http://feeds.feedburner.com/CasesBlog

"What is the minimal webmaster competence for running a medical blog?", asked a relatively new blogger recently. My suggestions are listed below.

Keep it simple, and free

If your blog content is great and compelling, you don't need much HTML, CSS, etc. knowledge. Knowing HTML doesn't hurt, of course, but it's not essential.

Keep it simple, and free. Many doctors are wrongly advised to spend time and money on custom installations of WordPress, hosting, and social media consultatants when all they need is a free Google/Blogger blog with a custom domain name.

"Blogging is teaching, whether it’s yourself or others, and that’s the best feeling in the world" 

Speaking from personal experience, my blogs reached more than 8 million page views and I've never used outside help for blog launch or maintenance. I don't think my blog content is that great or original apart from a few mind map diagrams, mnemonics and social media how-to articles - it's just my personal digital netbook that I share with the world.

I typically publish one post per day during the week at CasesBlog and AllergyNotes. They are scheduled 2-3 months in advance, and publish automatically, unless I edit them the day before they are due for posting.

"Blogging is teaching, whether it’s yourself or others, and that’s the best feeling in the world" http://goo.gl/hCpF8

Comments from Google Plus:

Ahmad Gandour, Jan 25, 2012: This is a great advice i will consider starting a blog in the near future .you really post interesting post i check your post every day in the morning while i am checking journal watch and BEJM news letter thanks for these great post .?

Ves Dimov, M.D., Jan 25, 2012: Thank you for your interest. I typically publish one post per day during the week at CasesBlog and AllergyNotes. They are scheduled 2-3 months in advance, and publish automatically, unless I edit them the day before they are due for posting.?

Ahmad Gandour, Jan 25, 2012: Thanks for the info i booked marked the both pages i am going to check it every day?

Ves Dimov, M.D., Jan 25, 2012: You can subscribe to the RSS feeds - this way there is no need to visit the website every day - the new post gets delivered to your RSS reader (Google Reader) or email.?

Ahmad Gandour, Jan 25, 2012: Done :)?

Jill Celeste, Jan 25, 2012: Blogger is the perfect tool for a doctor. Great post!?

Source:
http://feeds.feedburner.com/CasesBlog

What happened to "Grand Rounds" medblog carnival?

It's sad to see the demise of "Grand Rounds" medblog carnival. The weekly summary of the best medical blog posts has been published since 2004, with only few breaks. There have not been any editions for more than a month, and no new ones are scheduled. A new initiative by Health Care SoMedia Review could replace some of it http://goo.gl/73RpE

This blog post is a part of a project to recreate a weekly review, or blog carnival, of the best medical blog posts. Feel free to send your suggestions to my email at clinicalcases@gmail.com. The “Best of Medical Blogs - weekly review, blog carnival” will be published on Tuesdays, just like the old Grand Rounds. The last organizers of the Grand Rounds blog carnival. @DrVal and @NickGenes, are aware of this project.

How Doctors Manage Their Social Media Profiles

Personal vs. Professional: How Doctors Manage Their Social Media Profiles is a blog post by Matt Wood of the University of Chicago Medicine blog http://goo.gl/JNyu1. Matt has published a series of great blog posts recently about physicians’ use social media. The doctors at University of Chicago are clearly the leaders in social media use in a city with a rich history of great medical centers such as UChicago Medicine, Northwestern, Childrens’ Memorial, Rush, Loyola and Northshore. Matt tries to find out what makes the UChicago doctors more comfortable using social media that their peers at other institutions: http://goo.gl/JNyu1

Consumers use social media to make medical decisions

Consumer Expectations for Healthcare Social Media - this is a succinct summary by Ed Bennett, “a maker of lists” of healtchare oragnizations that use social media http://goo.gl/REXqV

Digital Strategies for Healthcare Organisations - a good overview by the Australian blog IV line http://goo.gl/PZtWl

Doctors’ salaries

Dr. Mandrola quotes an experienced colleague on doctors' salaries: “We are all happy with what we make. What upsets us most is seeing what others make.” Since then, I try not to dwell on what others make. http://goo.gl/WBnJq

Healthcare social media is a “moral obligation” for doctors

Healthcare social media is a 'moral obligation', says Farris Timimi, M.D., medical director for the Mayo Clinic Center for Social Media, quoted by “Fierce Health IT” . Social media needs to be grown and nurtured for patients. "Our patients are there. Our moral obligation is to meet them where they're at and give them the information they need so they can seek recovery," Dr. Timimi said. "You've got to be ready for it. You build it for the patients; not for yourself. "This is not marketing," he added. "This is the right thing to do." http://goo.gl/BHzKf

Social media is no more a moral obligation for doctors than it is to appear on TV and radio shows, and to write newspaper columns. It is great if you have the time and aptitude to do it, but the most important things is to focus on what matters most - providing correct diagnosis and best possible treatment to your patients.

Comments from Twitter:

Westby Fisher, MD @doctorwes: Best of Medical Blogs - weekly review, RIP blog carnival bit.ly/KsBSLJ

Laika (Jacqueline) @laikas: After the demise of THE Grand Rounds @DrVes starts his own weekly blog review bit.ly/Iqgcmx Gr8 initiative; but still miss the OLD GR

WB Medical Education @WBmeded: Hope to check out some of these later, looks interesting RT @DrVes: Best of Medical Blogs: weekly review, blog carnival goo.gl/fb/d870P

Mike Cadogan @sandnsurf: Another great way to control the information overload with the Best of Medical Blogs - weekly review bit.ly/K1stxo

Source:
http://feeds.feedburner.com/CasesBlog

These are excerpts from a review in the Medical Journal of Australia (MJA):

Older people with mild cognitive impairment are at increased risk of progressing to dementia, but no tests are helpful in assessing this risk. Medications are not beneficial in mild cognitive impairment.

Physical activity and treatment of hypertension decrease the risk of dementia.

In people with Alzheimer’s disease, a cholinesterase inhibitor or memantine (an N-methyl- D-aspartate receptor antagonist) provides symptomatic relief. Medications do not change progression of the illness.

Behavioural and psychological symptoms are common in Alzheimer’s disease.

Atypical antipsychotics reduce agitation and psychosis but increase the risk of cardiovascular events.

Antidepressant role in managing depression with mild cognitive impairment is uncertain but they may increase the risk of delirium and falls.

References:

Memory loss. Leon A Flicker, Andrew H Ford, Christopher D Beer and Osvaldo P Almeida. Med J Aust 2012; 196 (2): 114-117.

Image source: Hippocampus, from Wikipedia, public domain.

Source:
http://feeds.feedburner.com/CasesBlog

Public release date: 2-May-2012 [ | E-mail | Share ]

Contact: Rachel Seroka rseroka@aan.com 651-695-2738 American Academy of Neurology

MINNEAPOLIS A new study suggests that eating foods that contain omega-3 fatty acids, such as fish, chicken, salad dressing and nuts, may be associated with lower blood levels of a protein related to Alzheimer's disease and memory problems. The research is published in the May 2, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

"While it's not easy to measure the level of beta-amyloid deposits in the brain in this type of study, it is relatively easy to measure the levels of beta-amyloid in the blood, which, to a certain degree, relates to the level in the brain," said study author Nikolaos Scarmeas, MD, MS, with Columbia University Medical Center in New York and a member of the American Academy of Neurology.

For the study, 1,219 people older than age 65, free of dementia, provided information about their diet for an average of 1.2 years before their blood was tested for the beta-amyloid. Researchers looked specifically at 10 nutrients, including saturated fatty acids, omega-3 and omega-6 polyunsaturated fatty acids, mono-unsaturated fatty acid, vitamin E, vitamin C, beta-carotene, vitamin B12, folate and vitamin D.

The study found that the more omega-3 fatty acids a person took in, the lower their blood beta-amyloid levels. Consuming one gram of omega-3 per day (equal to approximately half a fillet of salmon per week) more than the average omega-3 consumed by people in the study is associated with 20 to 30 percent lower blood beta-amyloid levels.

Other nutrients were not associated with plasma beta-amyloid levels. The results stayed the same after adjusting for age, education, gender, ethnicity, amount of calories consumed and whether a participant had the APOE gene, a risk factor for Alzheimer's disease.

"Determining through further research whether omega-3 fatty acids or other nutrients relate to spinal fluid or brain beta-amyloid levels or levels of other Alzheimer's disease related proteins can strengthen our confidence on beneficial effects of parts of our diet in preventing dementia," said Scarmeas.

###

The study was supported by the National Institute on Aging.

More here:
Eating fish, chicken, nuts may lower risk of Alzheimer's disease

01-05-2012 12:04 Daryl A. Bosco, PhD, assistant professor of neurology at the University of Massachusetts Medical School and a protein chemist investigating the causes of ALS (Lou Gehrig's Disease), talks about research at UMMS that identifies the toxic proteins that cause the disease and how that work indicates new therapeutic directions for ALS research, including RNA interference, immunotherapy and the search for small molecules that might target the rogue proteins.

See original here:
Daryl Bosco, PhD: Assistant Professor of Neurology - Video